Primary liver cancer , can it be cured?
Primary liver cancer has always been regarded as a very scary cancer . This malignant tumor has deprived many people of their lives. Statistics show that about 700,000 people are found to be liver cancer patients every year, and the number of people who die from liver cancer is also about 600,000 every year.
Among these patients, 55% are residents of our country. In other words, Half of the world's liver cancer patients come from China.
However, the prognosis of these patients is not good. Less than 10% of people who find liver cancer can survive more than 5 years.
Traditionally, there are many ways to treat liver cancer. Whether it is surgical resection, liver transplantation, or more sophisticated targeted therapy and immunotherapy , although these treatments are effective against cancer cells, it is a pity that not all patients have the opportunity for surgery, many Patients with huge tumors cannot undergo surgery.
However, it is now reported that a new microsphere injection has been officially launched and has been applied in many areas. As a new product for the treatment of liver tumors, is this technology reliable?
Especially for intermediate and advanced liver cancer, it can shrink the tumor, allowing patients who were originally inoperable to regain the opportunity to undergo surgery, and ultimately achieve the goal of cure.
Is this true? Is it reliable?
Its biggest feature is that has a certain degree of radioactivity . We can use the radioactive yttrium element to make tiny balls for radiotherapy.
This kind of microsphere can release very pure β-rays . Because of its high energy, it can destroy tumor cells, and its range is relatively short. The maximum medium and long distance in the human body is only 11 mm.
More importantly, after decays into , its products are harmless to the human body and will not cause other side damage.
If this substance is placed in the liver tumor tissue, its effect will be more prominent, because liver cancer cells are generally very sensitive to radiation.
So some scholars plan to try to put high-dose radioactive microspheres inside liver tumors. Wouldn't this be able to eliminate tumor cells at close range and defeat tumors?
Someone did do this in 1994. He used yttrium element glass microspheres to treat 24 patients with liver cancer. Among these patients, the condition of 7 patients was controlled, and the symptoms of 9 patients were partially ease.
Moreover, these patients did not have serious complications , so more and more people think this idea is reliable.
Until 1999, the U.S. Food and Drug Administration evaluated this treatment method and believed that the use of microspheres to treat inoperable liver cancer was very effective, and recommended the use of such radioactive microspheres for such patients.
After that, more and more related research was carried out, and many scholars devoted themselves to the research of radioactive microspheres. Currently, two types of microspheres have been approved worldwide: one is glass radioactive microspheres, and the other One is resin radioactive microspheres.
But, which patients can use it?
2. Not all patients can use it.
Some patients are indeed suitable. As mentioned above, patients who are inoperable and whose tumors are particularly large can use this treatment method.
Many patients want to undergo arterial chemoembolization. This surgery has very high requirements on the number of tumors and whether they are combined with portal vein emboli. Some patients are not suitable for this treatment. For this group of people, some scholars It is recommended to use Yttrium-90 radioactive microspheres.
In addition, for many people whose tumors are very large and cannot undergo surgery, doctors will also recommend the use of this treatment measure. The tumors can be made smaller, allowing them to undergo surgical resection or transplantation.
In short, many patients who were originally on the road to death now have hope.
However, there are many contraindications to the treatment, and some people cannot use it:
. The kidney function is very poor, creatinine exceeds 188 μmol/L.
. Have blood system diseases.
In fact, these are just more serious cases. In addition, patients who also have most of the thrombosis of the main portal vein have a very high risk of postoperative liver failure, so this surgical treatment is not recommended.
3. Is it available in China?
In the past, this treatment was very well prescribed abroad, but it has not been applied in our country. However, with the improvement of treatment technology, this technology can really be accessed in our lives.
In September 2019, our country reported a similar treatment plan . After shrinking the tumor, liver cancer surgery was performed. This treatment method greatly improved the prognosis of the patient. Some patients were even cured as a result.
In 2022, there were news reports that this treatment method was approved by my country's State Food and Drug Administration, and many domestic tertiary hospitals have started this treatment.
Many patients with liver cancer that were originally untreatable may even be eventually cured.
summary.
Science and technology are constantly updated and iterated. Many diseases that were originally untreatable have gradually found methods. Diseases that were previously considered terminal illnesses even have hope of cure.
Liver cancer is like this. Like liver cancer, many other cancers may find solutions in the future.
Most importantly, don’t give up.
html He suddenly fainted at the age of 1936 and was diagnosed with cerebral infarction? These three thoughts hurt him. The doctor felt very sorry.
